A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2

Clinical trial NCT05214690 · COMPLETED

Trial details

NCT number: NCT05214690
Sponsor: Daewon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Osteoarthritis Rheumatoid Arthritis Back Pain Acute Upper Respiratory Tract Infection

Start date: 2020-08-13
Primary completion: 2020-09-08
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.